Company / Inventory
ADMA Biologics, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$206.5M
FY2025
5-year range
$124.7M / $206.5M
FY2021-FY2025
Trend
+21.3%
vs FY2024
Sector context
#28 of 105
Health Care
What the data says
At $206M, ADMA Biologics, Inc.'s inventory ranks #28 of 105 in the Health Care sector. Improved from $173M to $206M over the past 2 years.
Based on SEC 10-K filings.
$206M in FY2025 with a 5-year CAGR of +20.4%.
Improved from $173M to $206M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +8.1%
- 5-Year CAGR
- +20.4%
- 10-Year CAGR
- -
Sector benchmark
#28 of 105 in Health CareTop 27% of 105This company $206.5M Sector average $885.3M
▼
-76.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +20.4%, indicating consistent growth.
- In FY2025, inventory increased 21.3% year-over-year.
- Ranks #28 out of 105 companies in the Health Care sector.
- Lowest inventory in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $206.5M | +21.3% |
| FY2024 | $170.2M | -1.5% |
| FY2023 | $172.9M | +5.9% |
| FY2022 | $163.3M | +30.9% |
| FY2021 | $124.7M | +53.0% |
| FY2020 | $81.5M | +53.7% |
| FY2019 | $53.1M | +185.0% |
| FY2018 | $18.6M | +47.4% |
| FY2017 | $12.6M | +151.6% |
| FY2016 | $5.0M | +45.7% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026